SLC6A3 and Parkinson disease: In line with our findings, previous studies in PD patients (who were characterized by an altered striatal DAT expression due to nigrostriatal dopaminergic degeneration) have shown altered fecal P. copri levels compared to controls [94], underscoring the role of the gut-brain axis and more specific the enteric nervous system in human disease [95,96].